Covid-19 man­u­fac­tur­ing roundup: Mod­er­na eyes Nexus' Wis­con­sin plant for vac­cine boost; Catal­ent wraps up plant project

Af­ter an im­me­di­ate de­mand for Covid-19 vac­cines has opened back up fol­low­ing the CDC’s pause on J&J’s jab, Mod­er­na is look­ing to boost pro­duc­tion of its own.

The com­pa­ny met with Nexus Phar­ma­ceu­ti­cals to talk about mak­ing the shot at the com­pa­ny’s Pleas­ant Prairie, WI plant, Reuters re­port­ed.

Pres­i­dent Joe Biden has said that there will be enough vac­cines for all US adults by May. This move could help the coun­try reach that mile­stone. Ac­cord­ing to Reuters, White House of­fi­cials have fa­cil­i­tat­ed dis­cus­sions be­tween Nexus, Mod­er­na and J&J.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER